Zynex Quick Ratio 2010-2025 | ZYXI
Historical quick ratio values for Zynex (ZYXI) over the last 10 years.
| Zynex Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $0.04B | $0.02B | 2.63 |
| 2024-12-31 | $0.06B | $0.02B | 3.63 |
| 2024-09-30 | $0.06B | $0.02B | 3.15 |
| 2024-06-30 | $0.06B | $0.02B | 3.22 |
| 2024-03-31 | $0.06B | $0.02B | 2.87 |
| 2023-12-31 | $0.08B | $0.02B | 4.03 |
| 2023-09-30 | $0.09B | $0.02B | 4.47 |
| 2023-06-30 | $0.09B | $0.01B | 6.62 |
| 2023-03-31 | $0.05B | $0.02B | 2.42 |
| 2022-12-31 | $0.06B | $0.02B | 2.66 |
| 2022-09-30 | $0.05B | $0.02B | 2.68 |
| 2022-06-30 | $0.06B | $0.02B | 2.98 |
| 2022-03-31 | $0.07B | $0.02B | 3.07 |
| 2021-12-31 | $0.07B | $0.02B | 3.15 |
| 2021-09-30 | $0.06B | $0.01B | 5.90 |
| 2021-06-30 | $0.05B | $0.01B | 5.83 |
| 2021-03-31 | $0.05B | $0.01B | 5.35 |
| 2020-12-31 | $0.05B | $0.01B | 5.38 |
| 2020-09-30 | $0.05B | $0.01B | 7.08 |
| 2020-06-30 | $0.03B | $0.01B | 4.17 |
| 2020-03-31 | $0.02B | $0.01B | 3.82 |
| 2019-12-31 | $0.02B | $0.01B | 3.89 |
| 2019-09-30 | $0.02B | $0.01B | 3.65 |
| 2019-06-30 | $0.01B | $0.00B | 3.77 |
| 2019-03-31 | $0.01B | $0.00B | 2.99 |
| 2018-12-31 | $0.01B | $0.01B | 1.93 |
| 2018-09-30 | $0.01B | $0.00B | 3.23 |
| 2018-06-30 | $0.01B | $0.00B | 2.98 |
| 2018-03-31 | $0.01B | $0.00B | 2.04 |
| 2017-12-31 | $0.01B | $0.00B | 1.97 |
| 2017-09-30 | $0.01B | $0.00B | 1.18 |
| 2017-06-30 | $0.00B | $0.01B | 0.60 |
| 2017-03-31 | $0.00B | $0.01B | 0.51 |
| 2016-12-31 | $0.00B | $0.01B | 0.43 |
| 2016-09-30 | $0.00B | $0.01B | 0.47 |
| 2016-06-30 | $0.00B | $0.01B | 0.39 |
| 2016-03-31 | $0.00B | $0.01B | 0.38 |
| 2015-12-31 | $0.00B | $0.01B | 0.33 |
| 2015-09-30 | $0.00B | $0.01B | 0.37 |
| 2015-06-30 | $0.00B | $0.01B | 0.37 |
| 2015-03-31 | $0.00B | $0.01B | 0.42 |
| 2014-12-31 | $0.00B | $0.01B | 0.47 |
| 2014-09-30 | $0.01B | $0.01B | 0.61 |
| 2014-06-30 | $0.01B | $0.01B | 0.61 |
| 2014-03-31 | $0.01B | $0.01B | 0.81 |
| 2013-12-31 | $0.01B | $0.01B | 0.90 |
| 2013-09-30 | $0.01B | $0.01B | 1.12 |
| 2013-06-30 | $0.01B | $0.01B | 1.16 |
| 2013-03-31 | $0.01B | $0.01B | 1.26 |
| 2012-12-31 | $0.02B | $0.01B | 1.26 |
| 2012-09-30 | $0.02B | $0.01B | 1.15 |
| 2012-06-30 | $0.01B | $0.01B | 1.16 |
| 2012-03-31 | $0.01B | $0.01B | 1.24 |
| 2011-12-31 | $0.01B | $0.01B | 1.38 |
| 2011-09-30 | $0.01B | $0.01B | 1.33 |
| 2011-06-30 | $0.01B | $0.01B | 1.41 |
| 2011-03-31 | $0.01B | $0.01B | 1.44 |
| 2010-12-31 | $0.01B | $0.01B | 1.60 |
| 2010-09-30 | $0.01B | $0.01B | 1.86 |
| 2010-06-30 | $0.01B | $0.00B | 1.82 |
| 2010-03-31 | $0.01B | $0.01B | 1.73 |
| 2009-12-31 | $0.01B | $0.00B | 2.09 |
| 2009-09-30 | $0.01B | $0.00B | 1.67 |
| 2009-06-30 | $0.01B | $0.01B | 1.45 |
| 2009-03-31 | $0.01B | $0.01B | 1.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.066B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |